<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activated leukocytes appear to be directly involved in ischemic central <z:mp ids='MP_0008912'>nervous</z:mp> system injury </plain></SENT>
<SENT sid="1" pm="."><plain>A surface <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (CD18) on the leukocyte is required for endothelial adherence and subsequent function and can be blocked with leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> antibody treatment </plain></SENT>
<SENT sid="2" pm="."><plain>We used two animal models to determine the efficacy of anti-CD18 antibody treatment in preserving neurologic function after central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We gave a dose of 1 mg/kg anti-CD18 to treatment rabbits 30 minutes before inducing irreversible <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the brain with intraarterial microspheres or in the spinal cord using reversible aortic occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with anti-CD18 produced a significant reduction in neurologic deficits in the reversible spinal cord model, but not in the irreversible microsphere model </plain></SENT>
<SENT sid="5" pm="."><plain>This protective effect supports the active role of leukocytes in central <z:mp ids='MP_0008912'>nervous</z:mp> system reperfusion ischemic injury and offers potential for future therapy </plain></SENT>
</text></document>